Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study

Shun Kohsaka, Carolyn S.P. Lam, Dae Jung Kim, Matthew A. Cavender, Anna Norhammar, Marit E. Jørgensen, Kåre I. Birkeland, Reinhard W. Holl, Josep Franch-Nadal, Navdeep Tangri, Jonathan E. Shaw, Jenni Ilomäki, Avraham Karasik, Su Yen Goh, Chern En Chiang, Marcus Thuresson, Hungta Chen, Eric Wittbrodt, Johan Bodegård, Filip SurmontPeter Fenici, Mikhail Kosiborod

Research output: Contribution to journalArticlepeer-review

71 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases